You just read:

Oncolytics Biotech® Inc. Collaborators to Present Positive Phase 2 REOLYSIN Clinical Data in Pancreatic Cancer at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference

News provided by

Oncolytics Biotech Inc.

Nov 14, 2011, 07:00 EST